speb/financial-data huggingface dataset:
Financial ratios for NEU.AX — annual report dated 2024-12-31
Total revenue: 132449068.32298136
Gross profit: 132449068.32298136
Operating income: 109037267.08074534
Net income: 88225465.8385093
Capital expenditures: 6211.180124223602
Depreciation & amortization: 13664.596273291925
Net tangible assets: 226027329.19254658
Owner earnings: 88232919.25465837
Return on net tangible assets (%): 39.03639421385859
Capex to operating income (%): 0.005696382796923953
Buffett classification: The Great
Stock price: 7.763975155279502
P/E ratio: 11.156302668910119
Shares outstanding: 126773976
Book value: 226027329.19254655
P/B ratio: 4.354650402303904
Market cap (USD): 984269999.9999999
Debt to equity: 0
Current ratio: 8.726360874980879
Quick ratio: 8.726360874980879
Effective tax rate (%): 22.35541707663715
COGS to revenue (%): 0
R&D to revenue (%): 15.461234366427032
SG&A to revenue (%): 2.204527229498741
Free cash flow (dilution-adjusted): -7006211.180124223
Buyback yield (%): 0.6584947686739746
Retained earnings: 112068944.09937887
Receivables turnover: 1.3533223329313955
Capitalized R&D asset: 35588837.137614086
ROCI (R&D-adjusted, %): 43.463589009733894
Rosenberg metric: -1.4410437085883598
FCF margin (%): -5.289739874227994
Revenue growth (%): -16.621476877631657
Rule of 40 score: -21.91121675185965
Financial ratios for NUAI — annual report dated 2023-12-31
Total revenue: 612192
Operating income: -6125999
Net income: 10145
Capital expenditures: 1476612
Operating cash flow: -2682921
Depreciation & amortization: 885832
Net tangible assets: 528631
Owner earnings: -580635
Return on net tangible assets (%): -109.83748588334774
Buffett classification: The Gruesome
Stock price: 10.63
P/E ratio: 106133.32327649089
Shares outstanding: 101290928
Book value: 528631
P/B ratio: 2036.8131355141868
Market cap (USD): 1076722564.64
Debt to equity: 4.796674807190649
Current ratio: 0.7061888374854812
Quick ratio: 0.7061888374854812
Interest coverage ratio: -35.58668665005257
COGS to revenue (%): 0
SG&A to revenue (%): 955.9678989598035
Free cash flow (dilution-adjusted): -9158453
Buyback yield (%): 0.005506896757552845
Retained earnings: 10145
Receivables turnover: 0.8831352432115844
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -144.59664939815116
FCF margin (%): -1496.0099119230567
Rule of 40 score: -1496.0099119230567
Financial ratios for NUAI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.24
Shares outstanding: 101290928
Market cap (USD): 1138510030.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NUAI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6
Shares outstanding: 101290928
Market cap (USD): 607745568
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NUAI — annual report dated 2024-12-31
Total revenue: 532780
Operating income: -12732730
Net income: -13782384
Capital expenditures: 533054
Operating cash flow: -5349948
Depreciation & amortization: 903062
Net tangible assets: -2048838
Owner earnings: -13412376
Buffett classification: The Gruesome
Stock price: 6
Shares outstanding: 101290928
Book value: -2048838
Market cap (USD): 607745568
Debt to equity: -2.17271204458332
Current ratio: 0.646420866634689
Quick ratio: 0.646420866634689
Interest coverage ratio: -16.769037271170816
COGS to revenue (%): 0
SG&A to revenue (%): 2322.7482262847707
Free cash flow (dilution-adjusted): -12776707
Buyback yield (%): 0
Retained earnings: -13772239
Receivables turnover: 0.625839887983611
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -475.77114074649785
FCF margin (%): -2398.1206126356096
Revenue growth (%): -12.971747425644242
Rule of 40 score: -2411.0923600612537
Financial ratios for NUAI — quarterly report dated 2025-03-31
Total revenue: 326455
Operating income: -2069088
Net income: -3320256
Capital expenditures: 677547
Operating cash flow: -2830194
Depreciation & amortization: 198409
Net tangible assets: -2746901
Owner earnings: -3799394
Buffett classification: The Gruesome
Stock price: 1.14
Shares outstanding: 101290928
Book value: -2746901
Market cap (USD): 115471657.91999999
Debt to equity: -2.4320625315582904
Current ratio: 0.5149379303672964
Quick ratio: 0.5149379303672964
Interest coverage ratio: -1.434752399588939
COGS to revenue (%): 0
SG&A to revenue (%): 673.0281355776447
Free cash flow (dilution-adjusted): -3507741
Buyback yield (%): 0
Retained earnings: -17092495
Receivables turnover: 0.27850411159444893
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -171.89313669617
FCF margin (%): -1074.4944938812394
Rule of 40 score: -1074.4944938812394
Financial ratios for NUAI — quarterly report dated 2025-06-30
Total revenue: 209114
Operating income: -1863809
Net income: -3606004
Capital expenditures: 124999
Operating cash flow: -1849293
Depreciation & amortization: 232018
Net tangible assets: -137384
Owner earnings: -3498985
Buffett classification: The Gruesome
Stock price: 0.49
Shares outstanding: 101290928
Book value: -137384
Market cap (USD): 49632554.72
Debt to equity: -55.03593577126885
Current ratio: 0.7093331638614344
Quick ratio: 0.7093331638614344
Interest coverage ratio: -1.2294368153795616
COGS to revenue (%): 0
SG&A to revenue (%): 880.3356064156393
Free cash flow (dilution-adjusted): -1974292
Buyback yield (%): 0
Retained earnings: -20698499
Receivables turnover: 0.215701969554122
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -85.86828923993248
FCF margin (%): -944.1223447497537
Revenue growth (%): -35.9440045335498
Rule of 40 score: -980.0663492833035
Financial ratios for NUAI — quarterly report dated 2025-09-30
Total revenue: 159411
Operating income: -4203886
Net income: -5783173
Capital expenditures: 488501
Operating cash flow: -2501698
Depreciation & amortization: 236096
Net tangible assets: 12940969
Owner earnings: -6035578
Return on net tangible assets (%): -46.63930498558493
Buffett classification: The Gruesome
Stock price: 1.84
Shares outstanding: 101290928
Book value: 12940969
P/B ratio: 14.40195919795496
Market cap (USD): 186375307.52
Debt to equity: 0.2880440405969599
Current ratio: 2.1009863046343074
Quick ratio: 2.1009863046343074
Interest coverage ratio: -2.296786269609809
COGS to revenue (%): 0
SG&A to revenue (%): 2589.0314971990642
Free cash flow (dilution-adjusted): -2990199
Buyback yield (%): 0
Retained earnings: -26481672
Receivables turnover: 0.1686860328290738
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.46950452726569
FCF margin (%): -1875.7795886105725
Revenue growth (%): -23.768375144657938
Rule of 40 score: -1899.5479637552305
Financial ratios for NUAI — quarterly report dated 2025-12-31
Total revenue: 190420
Operating income: -4303842
Net income: -16876371
Capital expenditures: 375000
Operating cash flow: -4517927
Depreciation & amortization: 244056
Net tangible assets: -2609297
Owner earnings: -17007315
Buffett classification: The Gruesome
Stock price: 2.93
Shares outstanding: 101290928
Book value: -2609297
Market cap (USD): 296782419.04
Debt to equity: 0
Current ratio: 1.5748986116676658
Quick ratio: 1.5748986116676658
COGS to revenue (%): 0
SG&A to revenue (%): 2232.016594895494
Free cash flow (dilution-adjusted): -5057926
Buyback yield (%): 0
Retained earnings: -43358043
Receivables turnover: 0.05451474377326081
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -44.32456370267877
FCF margin (%): -2656.194727444596
Revenue growth (%): 19.452233534699612
Rule of 40 score: -2636.7424939098964
Financial ratios for NUAI — annual report dated 2025-12-31
Total revenue: 885400
Operating income: -12440625
Net income: -29585804
Capital expenditures: 1666047
Operating cash flow: -11699112
Depreciation & amortization: 910579
Net tangible assets: -2609297
Owner earnings: -30341272
Buffett classification: The Gruesome
Stock price: 2.93
Shares outstanding: 101290928
Book value: -2609297
Market cap (USD): 296782419.04
Debt to equity: 0
Current ratio: 1.5748986116676658
Quick ratio: 1.5748986116676658
Interest coverage ratio: -2.600804327320286
COGS to revenue (%): 0
SG&A to revenue (%): 1402.241472780664
Free cash flow (dilution-adjusted): -14340831
Buyback yield (%): 0
Retained earnings: -43358043
Receivables turnover: 0.2534783853421128
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -128.12395885202992
FCF margin (%): -1619.7008131917776
Revenue growth (%): 66.18491685123315
Rule of 40 score: -1553.5158963405445
Financial ratios for OESX — annual report dated 2022-03-31
Total revenue: 124383000
Gross profit: 33912000
Operating income: 8903000
Net income: 6091000
Capital expenditures: 396000
Operating cash flow: -113000
Depreciation & amortization: 1554000
Net tangible assets: 62346000
Owner earnings: 7249000
Return on net tangible assets (%): 11.627049048856382
Capex to operating income (%): 4.447938897001011
Buffett classification: The Great
Stock price: 28
P/E ratio: 18.64782531604006
Shares outstanding: 4056568
Book value: 65100000
P/B ratio: 1.744760430107527
Market cap (USD): 113583904
Debt to equity: 0.03542242703533026
Current ratio: 2.789213018395559
Quick ratio: 1.7098617611842821
Effective tax rate (%): 26.16969696969697
Interest coverage ratio: 111.2875
COGS to revenue (%): 72.73582402739925
R&D to revenue (%): 1.367550227925038
SG&A to revenue (%): 18.738895186641262
Free cash flow (dilution-adjusted): -1454000
Buyback yield (%): 0
Retained earnings: -57080000
Inventory turnover: 4.561869705526422
Receivables turnover: 7.819387690953668
Capitalized R&D asset: 1701000
ROCI (R&D-adjusted, %): 14.309135492700731
FCF margin (%): -1.1689700360981805
Rule of 40 score: -1.1689700360981805
Financial ratios for OESX — annual report dated 2023-03-31
Total revenue: 77383000
Gross profit: 17511000
Operating income: -15220000
Net income: -34341000
Capital expenditures: 586000
Operating cash flow: -2291000
Depreciation & amortization: 2022000
Net tangible assets: 25761000
Owner earnings: -32905000
Return on net tangible assets (%): -127.7318427079694
Buffett classification: The Gruesome
Stock price: 20.3
Shares outstanding: 4056568
Book value: 33249000
P/B ratio: 2.476716003488827
Market cap (USD): 82348330.4
Debt to equity: 0.30136244699088693
Current ratio: 2.059417682178785
Quick ratio: 1.3149586979635233
Interest coverage ratio: -44.89675516224189
COGS to revenue (%): 77.37099879818565
R&D to revenue (%): 2.3932905160048072
SG&A to revenue (%): 39.9041133065402
Free cash flow (dilution-adjusted): -4498000
Buyback yield (%): 0
Retained earnings: -91421000
Inventory turnover: 3.2887668223015654
Receivables turnover: 5.1424109516214775
Capitalized R&D asset: 2991670
ROCI (R&D-adjusted, %): -29.036911936354375
Rosenberg metric: -9.641975308641975
FCF margin (%): -5.812646188439322
Revenue growth (%): -37.78651423426031
Rule of 40 score: -43.59916042269963
Financial ratios for OESX — annual report dated 2024-03-31
Total revenue: 90581000
Gross profit: 20911000
Operating income: -10263000
Net income: -11671000
Capital expenditures: 731000
Operating cash flow: -10092000
Depreciation & amortization: 2590000
Net tangible assets: 16596000
Owner earnings: -9812000
Return on net tangible assets (%): -59.12268016389491
Buffett classification: The Gruesome
Stock price: 8.7
Shares outstanding: 4056568
Book value: 22542000
P/B ratio: 1.5656171413361724
Market cap (USD): 35292141.599999994
Debt to equity: 0.4437494454795493
Current ratio: 1.5977613802445372
Quick ratio: 0.9473496595729513
Interest coverage ratio: -13.647606382978724
COGS to revenue (%): 76.91458473631336
R&D to revenue (%): 1.6504564974994755
SG&A to revenue (%): 32.7651494242722
Free cash flow (dilution-adjusted): -11879000
Buyback yield (%): 0
Retained earnings: -103092000
Inventory turnover: 3.818371149841061
Receivables turnover: 4.88017886967297
Capitalized R&D asset: 3297170
ROCI (R&D-adjusted, %): -27.205946988146685
Rosenberg metric: 1.83585313174946
FCF margin (%): -13.11422925337543
Revenue growth (%): 17.05542561027616
Rule of 40 score: 3.941196356900729
Financial ratios for OESX — quarterly report dated 2024-09-30
Capital expenditures: 10000
Buffett classification: The Gruesome
Stock price: 8.6
Shares outstanding: 4056568
Market cap (USD): 34886484.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OESX — quarterly report dated 2024-12-31
Total revenue: 19584000
Gross profit: 5754000
Operating income: -1269000
Net income: -1508000
Capital expenditures: 19000
Operating cash flow: 3762000
Depreciation & amortization: 537000
Net tangible assets: 9276000
Owner earnings: -990000
Return on net tangible assets (%): -10.672703751617076
Buffett classification: The Gruesome
Stock price: 8
Shares outstanding: 4056568
Book value: 14475000
P/B ratio: 2.24197195164076
Market cap (USD): 32452544
Debt to equity: 0.7538514680483592
Current ratio: 1.3963584380407794
Quick ratio: 0.8895116996463772
Interest coverage ratio: -4.976470588235294
COGS to revenue (%): 70.61887254901961
R&D to revenue (%): 1.4654820261437909
SG&A to revenue (%): 34.39542483660131
Free cash flow (dilution-adjusted): 3561000
Buyback yield (%): 0
Retained earnings: -111983000
Inventory turnover: 1.0264974393230906
Receivables turnover: 1.358113730929265
Capitalized R&D asset: 287000
ROCI (R&D-adjusted, %): -4.07928937340702
FCF margin (%): 18.183210784313726
Rule of 40 score: 18.183210784313726
Financial ratios for OESX — annual report dated 2025-03-31
Total revenue: 79720000
Gross profit: 20236000
Operating income: -10128000
Net income: -11801000
Capital expenditures: 134000
Operating cash flow: 599000
Depreciation & amortization: 2619000
Net tangible assets: 7021000
Owner earnings: -9316000
Return on net tangible assets (%): -132.68765133171914
Buffett classification: The Gruesome
Stock price: 7.2
Shares outstanding: 4056568
Book value: 11884000
P/B ratio: 2.457698552675867
Market cap (USD): 29207289.6
Debt to equity: 0.8687310669808146
Current ratio: 1.3223811652510804
Quick ratio: 0.8980032781999702
Interest coverage ratio: -9.871345029239766
COGS to revenue (%): 74.61615654791771
R&D to revenue (%): 1.541645760160562
SG&A to revenue (%): 36.54666332162569
Free cash flow (dilution-adjusted): -663000
Buyback yield (%): 0
Retained earnings: -114893000
Inventory turnover: 5.221558988764045
Receivables turnover: 4.922506946588453
Capitalized R&D asset: 2841810
ROCI (R&D-adjusted, %): -36.626973488573704
Rosenberg metric: -0.451505016722408
FCF margin (%): -0.8316608128449574
Revenue growth (%): -11.99037325708482
Rule of 40 score: -12.822034069929776
Financial ratios for OESX — quarterly report dated 2025-03-31
Total revenue: 20869000
Gross profit: 5735000
Operating income: -2643000
Net income: -2911000
Capital expenditures: 7000
Operating cash flow: -699000
Depreciation & amortization: 700000
Net tangible assets: 7021000
Owner earnings: -2218000
Return on net tangible assets (%): -31.590941461330296
Buffett classification: The Gruesome
Stock price: 7.2
Shares outstanding: 4056568
Book value: 11884000
P/B ratio: 2.457698552675867
Market cap (USD): 29207289.6
Debt to equity: 0.8687310669808146
Current ratio: 1.3223811652510804
Quick ratio: 0.8980032781999702
Interest coverage ratio: -11.694690265486726
COGS to revenue (%): 72.51904739086683
R&D to revenue (%): 1.8640088169054578
SG&A to revenue (%): 38.28166179500695
Free cash flow (dilution-adjusted): -1084000
Buyback yield (%): 0
Retained earnings: -114893000
Inventory turnover: 1.3284761235955056
Receivables turnover: 1.2886075949367088
Capitalized R&D asset: 581290
ROCI (R&D-adjusted, %): -9.462999582574595
Rosenberg metric: -0.06620209059233449
FCF margin (%): -5.194307345823949
Revenue growth (%): 6.561478758169935
Rule of 40 score: 1.3671714123459857
Financial ratios for OESX — quarterly report dated 2025-06-30
Total revenue: 19575000
Gross profit: 5901000
Operating income: -1013000
Net income: -1244000
Capital expenditures: 55000
Operating cash flow: -515000
Depreciation & amortization: 484000
Net tangible assets: 6183000
Owner earnings: -815000
Return on net tangible assets (%): -13.181303574316674
Buffett classification: The Gruesome
Stock price: 6
Shares outstanding: 4056568
Book value: 10806000
P/B ratio: 2.2523975569128263
Market cap (USD): 24339408
Debt to equity: 0.7853044604849158
Current ratio: 1.230256468195684
Quick ratio: 0.8423153692614771
Interest coverage ratio: -5.994082840236686
COGS to revenue (%): 69.8544061302682
R&D to revenue (%): 1.0625798212005109
SG&A to revenue (%): 34.25798212005108
Free cash flow (dilution-adjusted): -736000
Buyback yield (%): 0
Retained earnings: -116137000
Inventory turnover: 1.327443937481798
Receivables turnover: 1.1511997177134792
Capitalized R&D asset: 563340
ROCI (R&D-adjusted, %): -4.7754828246192
Rosenberg metric: 0.4267352185089974
FCF margin (%): -3.7598978288633464
Revenue growth (%): -6.200584599166228
Rule of 40 score: -9.960482428029575
Financial ratios for OESX — quarterly report dated 2025-09-30
Total revenue: 19919000
Gross profit: 6177000
Operating income: -242000
Net income: -581000
Capital expenditures: 255000
Operating cash flow: 1819000
Depreciation & amortization: 510000
Net tangible assets: 7003000
Owner earnings: -326000
Return on net tangible assets (%): -4.655147793802656
Buffett classification: The Gruesome
Stock price: 8.76
Shares outstanding: 4056568
Book value: 11382000
P/B ratio: 3.1220818555614125
Market cap (USD): 35535535.68
Debt to equity: 0.8700579862941487
Current ratio: 1.3363674321503132
Quick ratio: 0.9010855949895615
Interest coverage ratio: -0.8642857142857143
COGS to revenue (%): 68.98940709874994
R&D to revenue (%): 1.1596967719263016
SG&A to revenue (%): 31.065816557056074
Free cash flow (dilution-adjusted): 1405000
Buyback yield (%): 0
Retained earnings: -116718000
Inventory turnover: 1.3181774580335732
Receivables turnover: 1.3034288705666797
Capitalized R&D asset: 498730
ROCI (R&D-adjusted, %): -1.173789085233856
Rosenberg metric: 1.3269230769230769
FCF margin (%): 7.053566946131834
Revenue growth (%): 1.7573435504469987
Rule of 40 score: 8.810910496578833
Financial ratios for OESX — quarterly report dated 2025-12-31
Total revenue: 21089000
Gross profit: 6507000
Operating income: 386000
Net income: 160000
Capital expenditures: 252000
Operating cash flow: -897000
Depreciation & amortization: 332000
Net tangible assets: 7585000
Owner earnings: 240000
Return on net tangible assets (%): 3.1641397495056034
Capex to operating income (%): 65.28497409326425
Buffett classification: The Good
Stock price: 15.38
P/E ratio: 97.48439975000001
Shares outstanding: 4056568
Book value: 11839000
P/B ratio: 5.269872104062843
Market cap (USD): 62390015.84
Debt to equity: 0.83148914604274
Current ratio: 1.3537058435127105
Quick ratio: 0.9465582700561241
Effective tax rate (%): 10.112359550561797
Interest coverage ratio: 1.9014778325123152
COGS to revenue (%): 69.14505192280336
R&D to revenue (%): 1.1238086206078999
SG&A to revenue (%): 27.900801365640852
Free cash flow (dilution-adjusted): -643000
Buyback yield (%): 0
Retained earnings: -116558000
Inventory turnover: 1.4780052706263938
Receivables turnover: 1.2508303677342822
Capitalized R&D asset: 460410
ROCI (R&D-adjusted, %): 1.624494490131366
Rosenberg metric: 1.4285714285714286
FCF margin (%): -3.048982882071222
Revenue growth (%): 5.873788844821528
Rule of 40 score: 2.8248059627503057
Financial ratios for ORMP — annual report dated 2021-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.35
Shares outstanding: 40926081
Market cap (USD): 750993586.35
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORMP — annual report dated 2022-12-31
Total revenue: 2703000
Operating income: -40598000
Net income: -36561000
Capital expenditures: 472000
Operating cash flow: -27918000
Depreciation & amortization: 58000
Net tangible assets: 151812000
Owner earnings: -36975000
Return on net tangible assets (%): -24.35578215160857
Buffett classification: The Gruesome
Stock price: 11.21
Shares outstanding: 40926081
Book value: 151156000
P/B ratio: 3.0351515521051105
Market cap (USD): 458781368.01000005
Debt to equity: 0.005914419540077801
Current ratio: 27.34232509571876
Quick ratio: 27.34232509571876
COGS to revenue (%): 0
R&D to revenue (%): 1022.5305216426193
SG&A to revenue (%): 579.4302626711062
Free cash flow (dilution-adjusted): -39923000
Buyback yield (%): 0
Retained earnings: -163081000
Capitalized R&D asset: 27639000
ROCI (R&D-adjusted, %): -12.080529599258998
FCF margin (%): -1476.988531261561
Rule of 40 score: -1476.988531261561
Financial ratios for ORMP — annual report dated 2023-12-31
Total revenue: 1340000
Operating income: -15769000
Net income: 5525000
Capital expenditures: 254000
Operating cash flow: -10295000
Depreciation & amortization: 196000
Net tangible assets: 163821000
Owner earnings: 5467000
Return on net tangible assets (%): 3.3371789941460497
Buffett classification: The Gruesome
Stock price: 2.15
P/E ratio: 15.925986271493212
Shares outstanding: 40926081
Book value: 162893000
P/B ratio: 0.5401771356043538
Market cap (USD): 87991074.14999999
Debt to equity: 0.31690741775275794
Current ratio: 3.055286202878942
Quick ratio: 3.055286202878942
Effective tax rate (%): 0
Interest coverage ratio: -7.741286205203731
COGS to revenue (%): 0
R&D to revenue (%): 669.4776119402985
SG&A to revenue (%): 628.7313432835821
Free cash flow (dilution-adjusted): -14761000
Buyback yield (%): 0
Retained earnings: -157556000
Capitalized R&D asset: 27489130
ROCI (R&D-adjusted, %): -9.752969652137184
FCF margin (%): -1101.5671641791046
Revenue growth (%): -50.425453200147984
Rule of 40 score: -1151.9926173792526
Financial ratios for ORMP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.27
Shares outstanding: 40926081
Market cap (USD): 92902203.87
Buyback yield (%): 1.3896333415367879
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORMP — annual report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -12781000
Net income: -19060000
Capital expenditures: 18000
Operating cash flow: -8412000
Depreciation & amortization: 193000
Net tangible assets: 146265000
Owner earnings: -18885000
Return on net tangible assets (%): -12.911496256794175
Buffett classification: The Gruesome
Stock price: 2.26
Shares outstanding: 40926081
Book value: 145347000
P/B ratio: 0.6363594918367768
Market cap (USD): 92492943.05999999
Debt to equity: 0.002559392350719313
Current ratio: 25.19278803869833
Quick ratio: 25.19278803869833
Interest coverage ratio: -14.98358733880422
Free cash flow (dilution-adjusted): -12483000
Buyback yield (%): 2.6856102939535984
Retained earnings: -176616000
Capitalized R&D asset: 21455440
ROCI (R&D-adjusted, %): -12.141784709251564
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for ORMP — quarterly report dated 2024-12-31
Capital expenditures: 11000
Buffett classification: The Gruesome
Stock price: 2.26
Shares outstanding: 40926081
Market cap (USD): 92492943.05999999
Buyback yield (%): 1.2898281323215148
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORMP — quarterly report dated 2025-03-31
Total revenue: 2000000
Gross profit: 13000
Operating income: -4500000
Net income: -7642000
Capital expenditures: 3000
Operating cash flow: -3519000
Depreciation & amortization: 30000
Net tangible assets: 140812000
Owner earnings: -7615000
Return on net tangible assets (%): -5.407919779564241
Buffett classification: The Gruesome
Stock price: 2
Shares outstanding: 40926081
Book value: 139894000
P/B ratio: 0.5851013052739932
Market cap (USD): 81852162
Debt to equity: 0.0021516290905971664
Current ratio: 23.939548434085943
Quick ratio: 23.939548434085943
Interest coverage ratio: -1.7591868647380766
COGS to revenue (%): 99.35000000000001
R&D to revenue (%): 110.3
SG&A to revenue (%): 115.35
Free cash flow (dilution-adjusted): -5711000
Buyback yield (%): 0
Retained earnings: -184258000
Capitalized R&D asset: 2206000
ROCI (R&D-adjusted, %): -2.100014095605175
FCF margin (%): -285.55
Rule of 40 score: -285.55
Financial ratios for ORMP — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: 0
Operating income: -2489000
Net income: 13288000
Capital expenditures: 4000
Operating cash flow: -3535000
Depreciation & amortization: 30000
Net tangible assets: 154529000
Owner earnings: 13314000
Return on net tangible assets (%): 8.615858511994512
Buffett classification: The Gruesome
Stock price: 2.1
P/E ratio: 15.222240541976621
Shares outstanding: 40926081
Book value: 153583000
P/B ratio: 0.559598198368309
Market cap (USD): 85944770.10000001
Debt to equity: 0.005938157217921254
Current ratio: 26.814513945301922
Quick ratio: 26.814513945301922
Effective tax rate (%): -0.9593421653723162
Free cash flow (dilution-adjusted): -4339000
Buyback yield (%): 0
Retained earnings: -170970000
Capitalized R&D asset: 2512020
ROCI (R&D-adjusted, %): -1.5794095338517617
Rosenberg metric: -0.0058930190389845875
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for ORMP — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: 0
Operating income: -2427000
Net income: 48395000
Capital expenditures: 2128000
Operating cash flow: -1625000
Depreciation & amortization: 31000
Net tangible assets: 203282000
Owner earnings: 46298000
Return on net tangible assets (%): 22.775258015958126
Buffett classification: The Gruesome
Stock price: 2.46
P/E ratio: 1.8629958598101442
Shares outstanding: 40926081
Book value: 202330000
P/B ratio: 0.4975938282014531
Market cap (USD): 100678159.26
Debt to equity: 0.004250481886027777
Current ratio: 22.244974669063573
Quick ratio: 22.244974669063573
Effective tax rate (%): 18.60691998452507
Free cash flow (dilution-adjusted): -4472000
Buyback yield (%): 0.3585683356285074
Retained earnings: -122575000
Capitalized R&D asset: 2573760
ROCI (R&D-adjusted, %): -1.2622086226349298
Rosenberg metric: 0
Rule of 40 score: 0
Financial ratios for ORMP — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: 0
Operating income: -5672000
Net income: 10009000
Capital expenditures: 202000
Operating cash flow: -466000
Depreciation & amortization: 30000
Net tangible assets: 199744000
Owner earnings: 9837000
Return on net tangible assets (%): 4.924803748798462
Buffett classification: The Gruesome
Stock price: 2.66
P/E ratio: 1.6996623803278688
Shares outstanding: 40926081
Book value: 199744000
P/B ratio: 0.5450144958546941
Market cap (USD): 108863375.46000001
Debt to equity: 0.004130286767061839
Current ratio: 6.982657445247826
Quick ratio: 6.982657445247826
Effective tax rate (%): -2.1639277329794835
Free cash flow (dilution-adjusted): -2548000
Buyback yield (%): 3.682597552262229
Retained earnings: -123436000
Receivables turnover: 0
Capitalized R&D asset: 3101730
ROCI (R&D-adjusted, %): -2.3620965396162155
Rosenberg metric: 0
Rule of 40 score: 0
Financial ratios for ORMP — annual report dated 2025-12-31
Total revenue: 2000000
Gross profit: 13000
Operating income: -15088000
Net income: 64050000
Capital expenditures: 1933000
Operating cash flow: -9145000
Depreciation & amortization: 121000
Net tangible assets: 199744000
Owner earnings: 62238000
Return on net tangible assets (%): 31.158883370714513
Buffett classification: The Gruesome
Stock price: 2.66
P/E ratio: 1.6996623803278688
Shares outstanding: 40926081
Book value: 199744000
P/B ratio: 0.5450144958546941
Market cap (USD): 108863375.46000001
Debt to equity: 0.004130286767061839
Current ratio: 6.982657445247826
Quick ratio: 6.982657445247826
Effective tax rate (%): 15.012479422229303
COGS to revenue (%): 99.35000000000001
R&D to revenue (%): 319.05
SG&A to revenue (%): 436.00000000000006
Free cash flow (dilution-adjusted): -17070000
Buyback yield (%): 4.354999998821459
Retained earnings: -123436000
Receivables turnover: 0.4314063848144953
Capitalized R&D asset: 13578510
ROCI (R&D-adjusted, %): -7.069834962093322
Rosenberg metric: 0.002055660974067046
FCF margin (%): -853.5
Rule of 40 score: -853.5
Financial ratios for OZM.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.09022556390977443
Shares outstanding: 290201873
Market cap (USD): 26183627.639097743
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OZM.AX — annual report dated 2022-06-30
Operating income: -3369940.6896551726
Net income: -3375058.620689655
Capital expenditures: 258580.68965517243
Depreciation & amortization: 76560
Net tangible assets: 3751176.551724138
Owner earnings: -3557079.310344828
Return on net tangible assets (%): -94.82569698592037
Buffett classification: The Gruesome
Stock price: 0.11034482758620691
Shares outstanding: 290201873
Book value: 3789615.862068966
P/B ratio: 8.450005701606003
Market cap (USD): 32022275.641379315
Debt to equity: 0.012890943545729226
Current ratio: 7.246075692981167
Quick ratio: 7.246075692981167
Interest coverage ratio: -501.63371317113234
Free cash flow (dilution-adjusted): -3523548.9655172415
Buyback yield (%): 0.28558352895261974
Retained earnings: -6455930.344827587
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -88.27251097035352
Rule of 40 score: 0
Financial ratios for OZM.AX — annual report dated 2023-06-30
Operating income: -1937787.4172185431
Net income: -1936379.4701986755
Capital expenditures: 8799.337748344371
Depreciation & amortization: 87346.35761589404
Net tangible assets: 1665743.7086092716
Owner earnings: -1857832.4503311259
Return on net tangible assets (%): -111.53171047436999
Buffett classification: The Gruesome
Stock price: 0.026490066225165563
Shares outstanding: 290201873
Book value: 1638180.7947019867
P/B ratio: 4.69268523919887
Market cap (USD): 7687466.834437086
Debt to equity: 0.014591375589057966
Current ratio: 5.806231032604466
Quick ratio: 5.806231032604466
Interest coverage ratio: -511.7277019937041
Free cash flow (dilution-adjusted): -2059016.5562913907
Buyback yield (%): 0.3190106908786216
Retained earnings: -8135782.781456954
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -117.85964592872817
Rule of 40 score: 0
Financial ratios for OZM.AX — annual report dated 2024-06-30
Operating income: -1790529.3333333333
Net income: -1690246.6666666667
Capital expenditures: 399767.3333333333
Depreciation & amortization: 90226
Net tangible assets: 1891982
Owner earnings: -1999788
Return on net tangible assets (%): -105.69804575307799
Buffett classification: The Gruesome
Stock price: 0.03333333333333333
Shares outstanding: 290201873
Book value: 1891981.9999999998
P/B ratio: 5.112837102396676
Market cap (USD): 9673395.766666666
Debt to equity: 0.06055871567488486
Current ratio: 4.989077185174317
Quick ratio: 4.989077185174317
Interest coverage ratio: -1606.3361244019136
Free cash flow (dilution-adjusted): -1471117.3333333333
Buyback yield (%): 1.1417500396353404
Retained earnings: -9812061.333333334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -89.8964504914058
Rule of 40 score: 0
Financial ratios for QUCY — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.39
Shares outstanding: 22767254
Market cap (USD): 236551769.06
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QUCY — annual report dated 2022-12-31
Total revenue: 563698.9361702128
Gross profit: 193777.6595744681
Operating income: -28131957.446808513
Net income: -28071634.042553194
Capital expenditures: 700513.8297872341
Operating cash flow: -15712329.787234044
Depreciation & amortization: 404040.4255319149
Net tangible assets: 14995815.95744681
Owner earnings: -28368107.446808513
Return on net tangible assets (%): -189.17348363908883
Buffett classification: The Gruesome
Stock price: 7.1
Shares outstanding: 22767254
Book value: 14995815.95744681
P/B ratio: 10.779507021071904
Market cap (USD): 161647503.4
Debt to equity: 0.22901827864467444
Current ratio: 4.331851932515062
Quick ratio: 4.290493154443283
Interest coverage ratio: -91.39939998064453
COGS to revenue (%): 65.62390894490608
R&D to revenue (%): 947.2700268175445
SG&A to revenue (%): 4048.4087816606498
Free cash flow (dilution-adjusted): -26864074.46808511
Buyback yield (%): 0
Retained earnings: -45779036.17021277
Inventory turnover: 1.9816947722959612
Receivables turnover: 2.0447676527564465
Capitalized R&D asset: 5339751.063829787
ROCI (R&D-adjusted, %): -109.896547981819
FCF margin (%): -4765.677695012239
Rule of 40 score: -4765.677695012239
Financial ratios for QUCY — annual report dated 2023-12-31
Total revenue: 994976.6666666666
Gross profit: 566287.7777777778
Operating income: -29605202.22222222
Net income: -29217474.444444444
Capital expenditures: 1332045.5555555555
Operating cash flow: -24376494.444444444
Depreciation & amortization: 962680
Net tangible assets: -161576.66666666666
Owner earnings: -29586840
Buffett classification: The Gruesome
Stock price: 1.16
Shares outstanding: 22767254
Book value: 3610251.11111111
P/B ratio: 7.315284678874294
Market cap (USD): 26410014.639999997
Debt to equity: 2.2838608333184585
Current ratio: 0.9721725905646634
Quick ratio: 0.9057395222831467
Interest coverage ratio: -47.615415820051076
COGS to revenue (%): 43.08532081712692
R&D to revenue (%): 1070.9791072710807
SG&A to revenue (%): 1923.1657023782802
Free cash flow (dilution-adjusted): -30937016.666666664
Buyback yield (%): 0
Retained earnings: -77031134.44444445
Inventory turnover: 0.6287420270582982
Receivables turnover: 2.525962596259626
Capitalized R&D asset: 14233625.43498818
ROCI (R&D-adjusted, %): -115.12276590937243
Rosenberg metric: 0.06976170120113
FCF margin (%): -3109.3208215938057
Revenue growth (%): 76.50852304717256
Rule of 40 score: -3032.812298546633
Financial ratios for QUCY — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 3104565.625
Buffett classification: The Gruesome
Stock price: 4.32
Shares outstanding: 22767254
Book value: 6247755.208333333
P/B ratio: 15.742380102986992
Market cap (USD): 98354537.28
Debt to equity: 0.5841918222294841
Current ratio: 1.2973715624080047
Quick ratio: 1.2370598377970943
Buyback yield (%): 0
Retained earnings: -92387142.70833334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QUCY — annual report dated 2024-12-31
Total revenue: 931240.625
Gross profit: 598836.4583333334
Operating income: -19218705.208333336
Net income: -22498720.833333336
Capital expenditures: 85002.08333333334
Operating cash flow: -18051306.25
Depreciation & amortization: 725655.2083333334
Net tangible assets: 3104565.625
Owner earnings: -21858067.708333336
Return on net tangible assets (%): -704.0620282695212
Buffett classification: The Gruesome
Stock price: 4.32
Shares outstanding: 22767254
Book value: 6247755.208333333
P/B ratio: 15.742380102986992
Market cap (USD): 98354537.28
Debt to equity: 0.5841918222294841
Current ratio: 1.2973715624080047
Quick ratio: 1.2370598377970943
Interest coverage ratio: -19.512510774209584
COGS to revenue (%): 35.69476650212363
R&D to revenue (%): 653.1422575842487
SG&A to revenue (%): 1473.5188609281302
Free cash flow (dilution-adjusted): -19279172.916666668
Buyback yield (%): 0
Retained earnings: -92387142.70833334
Inventory turnover: 0.855815699841768
Receivables turnover: 4.182511871622728
Capitalized R&D asset: 14983958.681619387
ROCI (R&D-adjusted, %): -90.65673591503383
Rosenberg metric: 0.003054495524844504
FCF margin (%): -2070.267597772237
Revenue growth (%): -6.405782547664431
Rule of 40 score: -2076.6733803199013
Financial ratios for QUCY — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -2984266.304347826
Net income: -5437925
Capital expenditures: 1321.7391304347825
Operating cash flow: -4284861.956521739
Depreciation & amortization: 174835.86956521738
Owner earnings: -5264410.869565217
Buffett classification: The Gruesome
Stock price: 3.21
Shares outstanding: 22767254
Market cap (USD): 73082885.34
Interest coverage ratio: -89.91697779524465
Free cash flow (dilution-adjusted): -5829461.956521739
Buyback yield (%): 0
Capitalized R&D asset: 96465.21739130434
ROCI (R&D-adjusted, %): -3026.952344465979
Rule of 40 score: 0
Financial ratios for QUCY — quarterly report dated 2025-06-30
Total revenue: 337314.11764705885
Operating income: -6289204.705882353
Net income: -3930964.7058823532
Capital expenditures: 109.41176470588236
Operating cash flow: -3028331.7647058824
Depreciation & amortization: 398918.82352941175
Net tangible assets: -1748849.411764706
Owner earnings: -3532155.2941176477
Buffett classification: The Gruesome
Stock price: 1.41
Shares outstanding: 22767254
Book value: 2967469.4117647056
P/B ratio: 10.817913745877355
Market cap (USD): 32101828.139999997
Debt to equity: 1.2264785721563511
Current ratio: 0.5154447511191921
Quick ratio: 0.43143804331417135
Interest coverage ratio: -28.939207258317722
COGS to revenue (%): 0
R&D to revenue (%): 1034.5881130173655
SG&A to revenue (%): 821.7747814046602
Free cash flow (dilution-adjusted): -3468571.7647058824
Buyback yield (%): 0
Retained earnings: -116850464.70588236
Inventory turnover: 0
Receivables turnover: 1.4484460565401016
Capitalized R&D asset: 3554443.4603580562
ROCI (R&D-adjusted, %): -49.6683168780968
FCF margin (%): -1028.291311641793
Rule of 40 score: -1028.291311641793
Financial ratios for QUCY — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: -555087.0588235294
Buffett classification: The Gruesome
Stock price: 1.12
Shares outstanding: 22767254
Book value: 754823.5294117648
P/B ratio: 33.78183573566085
Market cap (USD): 25499324.480000004
Debt to equity: 4.00797849127182
Current ratio: 0.4986486398672629
Quick ratio: 0.4399241765394567
Buyback yield (%): 0
Retained earnings: -123414558.82352942
Capitalized R&D asset: 2370007.4040920716
Rule of 40 score: 0
Financial ratios for QUCY — annual report dated 2025-12-31
Total revenue: 631858.8235294118
Gross profit: 458578.82352941175
Operating income: -15253311.764705883
Net income: -19071432.94117647
Capital expenditures: 19528.235294117647
Operating cash flow: -12917161.176470589
Depreciation & amortization: 724376.4705882353
Net tangible assets: -555087.0588235294
Owner earnings: -18366584.70588235
Buffett classification: The Gruesome
Stock price: 1.12
Shares outstanding: 22767254
Book value: 754823.5294117648
P/B ratio: 33.78183573566085
Market cap (USD): 25499324.480000004
Debt to equity: 4.00797849127182
Current ratio: 0.4986486398672629
Quick ratio: 0.4399241765394567
Interest coverage ratio: -34.716929346807404
COGS to revenue (%): 27.423847471512623
R&D to revenue (%): 923.6177105831533
SG&A to revenue (%): 1653.0946972518059
Free cash flow (dilution-adjusted): -17301218.82352941
Buyback yield (%): 0
Retained earnings: -123414558.82352942
Inventory turnover: 0.6790970454796946
Receivables turnover: 4.843183580716721
Capitalized R&D asset: 13427595.881250001
ROCI (R&D-adjusted, %): -110.37175108984434
Rosenberg metric: -0.02305986786027151
FCF margin (%): -2738.146272436136
Revenue growth (%): -32.14870501065052
Rule of 40 score: -2770.2949774467866
Financial ratios for RKN.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.31884057971014496
Shares outstanding: 113294832
Market cap (USD): 36122989.913043484
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RKN.AX — annual report dated 2022-12-31
Total revenue: 34487837.83783784
Gross profit: 29416216.216216218
Operating income: 3136486.4864864866
Net income: 39039189.18918919
Capital expenditures: 143918.91891891893
Depreciation & amortization: 8873648.64864865
Net tangible assets: -9372972.972972972
Owner earnings: 47768918.918918915
Return on net tangible assets (%): -509.6453287197232
Capex to operating income (%): 4.588539422662645
Buffett classification: The Great
Stock price: 0.3581081081081081
P/E ratio: 1.0392582117761087
Shares outstanding: 113294832
Book value: 12105405.405405404
P/B ratio: 3.3515439249832557
Market cap (USD): 40571797.94594595
Debt to equity: 0.36246930118329984
Current ratio: 0.39975903614457836
Quick ratio: 0.3718875502008032
Effective tax rate (%): 24.51640033641716
COGS to revenue (%): 14.705536616903728
SG&A to revenue (%): 41.31107715214921
Free cash flow (dilution-adjusted): 5050000
Buyback yield (%): 3.319107581615519
Retained earnings: 30877027.027027026
Inventory turnover: 21.631123919308358
Receivables turnover: 26.18881477680862
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.88368371281007
FCF margin (%): 14.642843148779436
Rule of 40 score: 14.642843148779436
Financial ratios for RKN.AX — annual report dated 2023-12-31
Total revenue: 36460273.97260274
Gross profit: 31165753.424657535
Operating income: 3516438.3561643837
Net income: 3813698.6301369863
Capital expenditures: 113698.6301369863
Depreciation & amortization: 9856849.315068493
Net tangible assets: -8576712.328767123
Owner earnings: 13556849.315068493
Return on net tangible assets (%): -158.06580418463506
Capex to operating income (%): 3.2333463186599145
Buffett classification: The Great
Stock price: 0.35616438356164387
P/E ratio: 10.58069551724138
Shares outstanding: 113294832
Book value: 13441095.890410958
P/B ratio: 3.002105209947004
Market cap (USD): 40351584.00000001
Debt to equity: 0.2650835711373828
Current ratio: 0.4352785584394115
Quick ratio: 0.4091585386014217
Effective tax rate (%): 4.42443226311668
Interest coverage ratio: 34
COGS to revenue (%): 14.521340547039378
SG&A to revenue (%): 39.650961827472194
Free cash flow (dilution-adjusted): 3155479.4520547944
Buyback yield (%): 0.46848494445821737
Retained earnings: 32978082.191780824
Inventory turnover: 24.462025316455698
Receivables turnover: 24.240437158469945
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.63715689305713
FCF margin (%): 8.654568680492936
Revenue growth (%): 5.719222364821236
Rule of 40 score: 14.37379104531417
Financial ratios for RKN.AX — annual report dated 2024-12-31
Total revenue: 33563354.03726708
Gross profit: 28503105.59006211
Operating income: 2773291.9254658385
Net income: 2745341.614906832
Capital expenditures: 222981.36645962732
Depreciation & amortization: 9721739.130434781
Net tangible assets: -6892546.583850931
Owner earnings: 12244099.378881987
Return on net tangible assets (%): -177.64260610975938
Capex to operating income (%): 8.040313549832026
Buffett classification: The Great
Stock price: 0.3540372670807453
P/E ratio: 14.610419511312216
Shares outstanding: 113294832
Book value: 14049689.440993788
P/B ratio: 2.854909559681697
Market cap (USD): 40110592.695652165
Debt to equity: 0.30778072502210435
Current ratio: 0.48784220370685255
Quick ratio: 0.46403672844754296
Effective tax rate (%): 18.553459119496853
Interest coverage ratio: 30.37414965986395
COGS to revenue (%): 15.076706700964154
SG&A to revenue (%): 39.81346114699187
Free cash flow (dilution-adjusted): 1913043.4782608694
Buyback yield (%): 0.19975826388416748
Retained earnings: 30962111.801242232
Inventory turnover: 29.09642857142857
Receivables turnover: 20.246159610340953
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.891211456288257
FCF margin (%): 5.6997982863593455
Revenue growth (%): -7.945414610741775
Rule of 40 score: -2.2456163243824294
Financial ratios for RKN.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -6892546.583850931
Buffett classification: The Gruesome
Stock price: 0.3540372670807453
Shares outstanding: 113294832
Book value: 14049689.440993788
P/B ratio: 2.854909559681697
Market cap (USD): 40110592.695652165
Debt to equity: 0.30778072502210435
Current ratio: 0.48784220370685255
Quick ratio: 0.46403672844754296
Buyback yield (%): 0
Retained earnings: 30962111.801242232
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCNX — annual report dated 2021-12-31
Capital expenditures: 22596
Buffett classification: The Gruesome
Stock price: 22.05
Shares outstanding: 40630815
Market cap (USD): 895909470.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCNX — annual report dated 2022-12-31
Total revenue: 10250168
Gross profit: 5519271
Operating income: -2040719
Net income: -3472099
Capital expenditures: 749
Operating cash flow: -1564668
Depreciation & amortization: 194704
Net tangible assets: 763136
Owner earnings: -3278144
Return on net tangible assets (%): -429.5622274404562
Buffett classification: The Gruesome
Stock price: 3.77
Shares outstanding: 40630815
Book value: 342867
P/B ratio: 446.75682567876174
Market cap (USD): 153178172.55
Debt to equity: 4.619595936616823
Current ratio: 0.9750008268154655
Quick ratio: 0.9444794579444389
Interest coverage ratio: -6.069847058053694
COGS to revenue (%): 46.15433620209932
R&D to revenue (%): 9.689450943633314
SG&A to revenue (%): 64.0653401973509
Free cash flow (dilution-adjusted): -1818774
Buyback yield (%): 0
Retained earnings: -19719536
Inventory turnover: 72.20208171176533
Receivables turnover: 16.27214841226122
Capitalized R&D asset: 993185
ROCI (R&D-adjusted, %): -53.9268064976282
FCF margin (%): -17.743845759406092
Rule of 40 score: -17.743845759406092
Financial ratios for SCNX — annual report dated 2023-12-31
Total revenue: 1363830
Gross profit: 49030
Operating income: -4396451
Net income: -17843574
Capital expenditures: 0
Operating cash flow: -2225192
Depreciation & amortization: 1049830
Net tangible assets: 542353
Owner earnings: -16793744
Return on net tangible assets (%): -3096.4600546138768
Buffett classification: The Gruesome
Stock price: 3.24
Shares outstanding: 40630815
Book value: 542353
P/B ratio: 242.7272285762225
Market cap (USD): 131643840.60000001
Debt to equity: 11.806133643586373
Current ratio: 0.23822935519028274
Quick ratio: 0.2381455917544935
Interest coverage ratio: -3.8456635319618306
COGS to revenue (%): 96.40497715990996
R&D to revenue (%): 0
SG&A to revenue (%): 318.6028317312275
Free cash flow (dilution-adjusted): -2482964
Buyback yield (%): 0
Retained earnings: -33245940
Inventory turnover: 1358.2644628099174
Receivables turnover: 0.5401944467109385
Capitalized R&D asset: 665433.9500000001
ROCI (R&D-adjusted, %): -287.91326697226907
Rosenberg metric: -5.507776496825868
FCF margin (%): -182.058174405901
Revenue growth (%): -86.69455954282896
Rule of 40 score: -268.75273394873
Financial ratios for SCNX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.58
Shares outstanding: 40630815
Market cap (USD): 307981577.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCNX — annual report dated 2024-12-31
Total revenue: 136643
Gross profit: 6005
Operating income: -14701015
Net income: 9065798
Capital expenditures: 12000
Operating cash flow: -14265238
Depreciation & amortization: 53361
Net tangible assets: -18700839
Owner earnings: 9107159
Return on net tangible assets (%): -48.69920007332291
Buffett classification: The Gruesome
Stock price: 6.05
P/E ratio: 27.114704160626566
Shares outstanding: 40630815
Book value: 79072121
P/B ratio: 3.1087623253459964
Market cap (USD): 245816430.75
Debt to equity: 0.044674418180840246
Current ratio: 0.7974658313954672
Quick ratio: 0.7974658313954672
Interest coverage ratio: -11.006793792596907
COGS to revenue (%): 95.60533653388758
R&D to revenue (%): 1636.885899753372
SG&A to revenue (%): 8821.541535241467
Free cash flow (dilution-adjusted): -14302822
Buyback yield (%): 0
Retained earnings: -39038973
Receivables turnover: 0.025072680552731843
Capitalized R&D asset: 2564441.05
ROCI (R&D-adjusted, %): -13.607442352026183
FCF margin (%): -10467.292140834144
Revenue growth (%): -89.9809360404156
Rule of 40 score: -10557.27307687456
Financial ratios for SCNX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.05
Shares outstanding: 40630815
Market cap (USD): 245816430.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0